CClinicalTrials.gg
Status unknownNCT04174183PREVISIONUpdated May 8, 2020

Evaluation of the Effectiveness of a Closed-incision Negative-pressure Therapy (Prevena®) on Bilateral Groin Incision

An interventional study of Closed-incision Negative-pressure Therapy - Dry dressing in Bilateral Vascular Groin Surgery, sponsored by Central Hospital, Nancy, France. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-05-08.

Sponsored by Central Hospital, Nancy, France · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Oct 2019), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
84
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Closed-incision negative-pressure therapy are medical device that are suspected to reduce groin wound complication in vascular surgery. The aim of this study is to compareon on the same patient a Closed-incision negative-pressure therapy (Prevena®, KCI) versus a traditional gauze dressings after a bilateral vascular groin surgery. To do this, each device is applied on one groin incision and the side, left or right, is randomized.

Read the detailed description

The prevalence of surgical site infections in groin vascular surgery is 3-44%. The factors causing these infections are well identified: disruption of lymphatic vessels, proximity of genital organs, presence of prosthetic material, etc. The risk of developing an infection of the surgical site is also influenced by the patient's comorbidities and by the surgical context.

Closed-incision negative-pressure therapy are medical device that are suspected to reduce groin wound complication in vascular surgery. The mechanisms of action for negative-pressure therapy include protecting the wound bed, splinting soft tissue, reducing oedema,increasing perfusion and enhancing development of granulation tissue.

Presently, there are no guidelines for the use of this device or not in groin incision and this decision is left to the surgeon's discretion.

The main objective is to demonstrate the superiority of closed-incision negative-pressure therapy over the application of a traditional gauze dressings to reduce the rate of major complications (i.e. requiring an extension of hospitalization time) during bilateral vascular groin surgery. To do this, each device is applied on one groin incision and the side, left or right, is randomized.

The secondary objectives are:

  1. To demonstrate the superiority of closed-incision negative-pressure therapy over the application of a dry dressing in reducing the score of complications (major and minor) during vascular groin surgery. The complication score is the number of complications observed during the consultation conducted on day four after the surgery, among the following:

    • Major :

      1. Presence of pus
      2. Bloody and/or lymphatic discharge
      3. Disunity
      4. Necrosis
    • Minor :

      1. Bruising 6) Hematoma 7) Wound extension
  2. To compare the rate of major complications between closed-incision negative-pressure therapy and dry dressing application in different clinical settings.
  1. To demonstrate the superiority of closed-incision negative-pressure therapy over the application of a dry dressing in reducing the score of complications 2-3 months after surgery.
02

Conditions studied

  • Bilateral Vascular Groin Surgery

Browse trials for

03

In context

Surgical Wound

519 studies on the registry are indexed under Surgical Wound; 71 are open to participants now.

This study's planned enrollment of 84 is close to the median of 80 across 412 interventional studies indexed under Surgical Wound.

Browse Surgical Wound studies →

Lead sponsor

Central Hospital, Nancy, France is the lead sponsor of 778 studies on the registry; 183 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Person affiliated to a health insurance system
  • Person who has received full information on the organization of the research and has signed his or her informed consent
  • Person presenting a bilateral vascular groin surgery
  • Major person

Exclusion criteria

Exclusion Criteria:

  • Person with a known allergy to one of the components of the evaluated product (including: acrylic or silver-based adhesives)
  • Person with a contraindication to the product(s) being evaluated
  • Non-collaborative or agitated patient
  • Patients with hemostasis problems
  • Persons referred to in Articles L. 1121-5, L. 1121-7 and L1121-8 of the Public Health Code:
  • Pregnant woman, parturient or breastfeeding mother
  • Minor person (not emancipated)
  • Adult person subject to a legal protection measure (guardianship, curatorship, protection of justice)
  • Adult person unable to consent
  • Persons deprived of their liberty by a judicial or administrative decision, persons undergoing psychiatric care pursuant to Articles L. 3212-1 and L. 3213-1.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
84 participants (estimated)

Study arms

  • Experimental
    Prevena (right side) - Dry dressing (left side)

    Device: Closed-incision Negative-pressure Therapy - Dry dressing

  • Experimental
    Prevena (left side) - Dry dressing (right side)

    Device: Closed-incision Negative-pressure Therapy - Dry dressing

Interventions

  • DeviceClosed-incision Negative-pressure Therapy - Dry dressing

    A Closed-incision Negative-pressure Therapy is applied on one groin incision - A dry dressing is applied on one groin incision .

06

What researchers measure

Primary outcomes

  1. Wound aspect - major complication

    Left and right wound incision are inspected and the presence of major complication are reported. Major complication : Presence of pus Bloody and/or lymphatic discharge Disunity Necrosis

    Time frame: 4 days

Secondary outcomes

  1. Score of complications

    Left and right wound incision are inspected and the presence of major and minor complication are reported. A score of complications is established. - Major : Presence of pus Bloody and/or lymphatic discharge Disunity Necrosis - Minor : Bruising Hematoma Wound extension Each complication amount to 1 point on the complication score.

    Time frame: 4-days

  2. Major complication in different clinical settings

    Left and right wound incision are inspected and the presence of major complication are reported. Major complication : Presence of pus Bloody and/or lymphatic discharge Disunity Necrosis During the analysis, patient are divided into several group depending of the presence or absence of comorbidities.

    Time frame: 4-days

  3. Wound aspect - major complication (long term)

    Left and right wound incision are inspected and the presence of major complication are reported. Major complication : Presence of pus Bloody and/or lymphatic discharge Disunity Necrosis

    Time frame: 2-3 months

07

Study locations

1 of 1 sites recruiting
  • Centre Hospitalier Régional Universitaire de Nancy
    Vandoeuvre-lès-Nancy, Grand Est 54500, France
    • Nicla Settembre, M.D. · Contact · n.settembre@chru-nancy.fr · +33 3 831 543 84
    • Nicla Settembre, Dr · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 8, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04174183
Lead sponsor
Central Hospital, Nancy, France
Responsible party
Sponsor
First posted
Nov 22, 2019
Start date
Dec 24, 2019
Primary completion
Jan 2022 (estimated)
Completion
Jul 2022 (estimated)
Last update
May 8, 2020

Study contacts

Nicla Settembre, M.D
Contact
n.settembre@chru-nancy.fr
+33 3 831 543 84
Nicla Settembre
principal investigator · Service de chirurgie vasculaire - Centre Hospitalier Régional Universitaire de Nancy - Allée du Morvan - 54511 Vandœuvre-lès-Nancy Cedex

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion